Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations, along with the key players, has fuelled the market growth. Other factors such as technologically advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases are driving the market growth. However, frequent product recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.
The world defibrillators market is segmented on the basis of product, end user, and geography. On the basis of product, the world defibrillator market is further segmented into implantable defibrillators and external defibrillators. Implantable defibrillators are further categorized into cardiac resynchronisation therapy- defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). Among these, the T-ICDs segment dominates the overall ICD market owing to higher precision and targeted functioning. In addition, external defibrillators segment is further categorized into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).
On the basis of end user, the defibrillator market is segmented into hospitals, prehospital, public access market, alternative care market, and home. Geographically, the market is segmented across four major regions such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the defibrillators market. The growth in this region is mainly due to factors such as product innovations, growing number of public defibrillation programs, and rising prevalence of chronic diseases. In addition, the Asia-Pacific region is expected to emerge as the area with maximum growth potential due to the growing focus of key players in emerging economies, improving healthcare infrastructure, and rising number of cardiovascular diseases.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Key Benefits of the Report
KEY MARKET SEGMENTS:
The world defibrillators market is segmented into product, end user, and geography.
By End User
SIMILAR MARKET STUDIES
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Artificial intelligence assists the machines to perform any task without human interventions. It uses different algorithms and software that help the machine to inculcate perception and reasoning for various situations. AI is widely applicable in the healthcare sector for various purposes such as drug discovery and precision medicine. In addition, ...
July 2017 | $5370 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and ...
July 2017 | $4960 | View Details >>
The Ursodeoxycholic Acid market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include ICE Grindeks ...
July 2017 | $3360 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, ...
July 2017 | $4960 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research